ETMarkets.comNEW DELHI: Shares of Ltd. traded 0.44 per cent down in Tuesday's trade at 01:11PM (IST). Around 136,527 shares changed hands on the counter.
The scrip opened at Rs 381.5 and touched an intraday high and low of Rs 382.3 and Rs 376.25, respectively, in the session so far. The stock of Biocon Ltd. quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 320.9.
Total market cap of the Biocon Ltd. stood at Rs 45288.0 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 2044.1 crore for the quarter ended 31-Mar-2021, up 8.79 per cent from previous quarter's Rs 1878.9 crore and up 24.33 per cent from the year-ago quarter's Rs 1644.1 crore.
The net profit for latest quarter stood at Rs 253.2 crore, up 105.19 per cent from the corresponding quarter last year.
As of 31-Mar-2021, DIIs held 2.51 per cent stake in the firm, while foreign institutional investors held 16.79 per cent and the promoters 60.67 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 61.16 and a price-to-book ratio of 4.84. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Biocon Ltd. belongs to the Pharma - Indian industry.
The scrip opened at Rs 381.5 and touched an intraday high and low of Rs 382.3 and Rs 376.25, respectively, in the session so far. The stock of Biocon Ltd. quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 320.9.
Total market cap of the Biocon Ltd. stood at Rs 45288.0 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 2044.1 crore for the quarter ended 31-Mar-2021, up 8.79 per cent from previous quarter's Rs 1878.9 crore and up 24.33 per cent from the year-ago quarter's Rs 1644.1 crore.
The net profit for latest quarter stood at Rs 253.2 crore, up 105.19 per cent from the corresponding quarter last year.
Shareholding pattern
As of 31-Mar-2021, DIIs held 2.51 per cent stake in the firm, while foreign institutional investors held 16.79 per cent and the promoters 60.67 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 61.16 and a price-to-book ratio of 4.84. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Biocon Ltd. belongs to the Pharma - Indian industry.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
